Henry J A
Poisons Unit, Guy's Hospital, London, UK.
Acta Psychiatr Scand Suppl. 1989;354:37-45. doi: 10.1111/j.1600-0447.1989.tb03045.x.
Since depressed patients are liable to attempt suicide by self-poisoning, fatal poisoning from overdose is an important part of the overall assessment of any antidepressant drug. Because prescription figures for drugs are available in Britain, a Fatal Toxicity Index can be calculated in terms of deaths (from national mortality data) per million National Health Service prescriptions. This was carried out for the years 1975-1984 (Cassidy and Henry 1987), and has since been updated. The older tricyclic antidepressants as a group had a higher Fatal Toxicity Index than the mean for this drugs studied. Monoamine oxidase inhibitors had intermediate toxicity, and newer drugs introduced since 1973 had lower toxicity than the mean figure for all drugs, which was 34.9 deaths per million prescriptions. If drugs are equally effective clinically, serious consideration should be given to prescribing antidepressants with a lower fatal toxicity as a contribution to suicide prevention.
由于抑郁症患者易于通过自我中毒尝试自杀,过量用药导致的致命中毒是任何抗抑郁药物整体评估的重要组成部分。因为英国有药品处方数据,所以可以根据每百万国民健康服务处方的死亡人数(来自国家死亡率数据)计算致命毒性指数。1975年至1984年进行了此项计算(卡西迪和亨利,1987年),此后一直在更新。作为一个群体,较老的三环类抗抑郁药的致命毒性指数高于所研究的此类药物的平均值。单胺氧化酶抑制剂具有中等毒性,1973年以来推出的新药毒性低于所有药物的平均数值,即每百万处方34.9例死亡。如果药物在临床上疗效相同,那么应认真考虑开具致命毒性较低的抗抑郁药,以作为预防自杀的一项措施。